Genetic engineering of IgG-glucuronidase fusion proteins

Author： Boado Ruben J.   Pardridge William M.  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.18, Iss.3, 2010-04, pp. : 205-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPCR-G fusion proteins: molecular analysis of receptor-G-protein coupling

By Seifert R.   Wenzel-Seifert K.   Kobilka B.K.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 9, 1999-09 ,pp. : 383-389

Elsevier

Access to resources Recommend Favorite

Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1333-1347

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into ligand pharmacology using receptor-G-protein fusion proteins

By Milligan G.G.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 1, 2000-01 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

G Protein-Coupled Receptor Fusion Proteins in Drug Discovery

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 1989-2001

Bentham Science Publishers

Access to resources Recommend Favorite

Chemical and Genetic Engineering Strategies to Improve the Potency of Pharmaceutical Proteins and Enzymes

By  

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-08 ,pp. : 1940-1955

Bentham Science Publishers

Access to resources Recommend Favorite